HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joël Fleury Selected Research

VEP protocol

4/2005Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joël Fleury Research Topics

Disease

1Prostatic Neoplasms (Prostate Cancer)
02/2006
1Peripheral Nervous System Diseases (PNS Diseases)
02/2006
1Breast Neoplasms (Breast Cancer)
04/2005

Drug/Important Bio-Agent (IBA)

2Paclitaxel (Taxol)FDA LinkGeneric
02/2006 - 04/2005
1Hormones (Hormone)IBA
02/2006
1Prednisone (Sone)FDA LinkGeneric
02/2006
1Mitoxantrone (Novantrone)FDA LinkGeneric
02/2006
1Carboplatin (JM8)FDA LinkGeneric
02/2006
1Vinorelbine (Navelbine)FDA LinkGeneric
04/2005
1Epirubicin (Ellence)FDA LinkGeneric
04/2005

Therapy/Procedure

1Neoadjuvant Therapy
04/2005
1Drug Therapy (Chemotherapy)
04/2005
1VEP protocol
04/2005